Amberstone Biosciences

Our Head of Research & Early Development, Aude Segaliny, will be in La Jolla this coming Thursday to present Amberstone's T-MATE platform at the 5th Annual Translational Oncology Symposium organized by Champions Oncology, Inc. with the great support of Mary T. and Rachel Bunting, MS, MBA. #TCellEngager #bispecific #multispecific #antibody #solidtumor #conditionalactivation #therapeuticindex #nextgenerationtreatment #OncologyInnovation #CancerResearch #ImmunoOncology

PepTalk will be ON in a week; looking forward to insightful and collaborative scientific discussions to start the year on the right foot! Amberstone Biosciences will be presenting its T-MATE T Cell Engagers platform and lead characterization at 4:20pm on January 15th in the BI AND MULTISPECIFIC BIOLOGICS, Characterization for Novel Biotherapeutics track. Please find the detailed program here: https://lnkd.in/gZYXQW3Z #CHIPepTalk #TCellEngager #TCE #antibody #bispecific #multispecific #tumortargeting #conditionalactivation #tumorspecific #gated #nextgentherapeutic #cancer #solidtumor #therapeuticwindow

Aude Segaliny, our Sr. Director of R&D will be presenting our conditionally activated CD3 T-MATE platform at the coming AET meeting in San Diego.

Amberstone Biosciences is excited to share that we will be part of the exiting “Innovative Concepts in Cell Engagers”?session at Antibody Engineering & Therapeutics US 2024 in San Diego. We look forward to seeing everyone in 2 weeks and catching up with the antibody enginering community. Download the Brochure: https://bit.ly/46Jm1dA ? 8 NEW topics from Protein-Based Degraders to Bi-Specifics & ADCs ? Pre-conference add-on options ? The brightest minds across the drug discovery landscape To join the event with an additional 10% off the currently advertised rate, click here https://lnkd.in/dJWkcwWE #BispecificAntibodies #ADCs #AntibodyEngineering #AntibodyTherapeutics Informa Connect

#SITC2024 is starting in a week with an exciting scientific agenda and groundbreaking updates from many teams! Amberstone Biosciences will be there to exchange and connect; Yang (Alice) Zhou will be presenting a poster on our T-MATE platform, showing how the pH-gating strategy can expand the therapeutic window of #TCellEngagers. #immunotherapy #antibodies #bispecific #solidtumors #TCells

I am excited to present a poster at the #SITC2024 Annual Meeting in Houston. Check it out if you are attending the conference and are interested in learning more about cutting-edge advances in cancer immunotherapy and antibody engineering! Looking forward to connecting with colleagues and discussing the latest innovations. #Oncology #AntibodyEngineering #Immunotherapy #AmberstoneBiosciences

We are attending SITC 2024.

We are attending SITC 2024.